Good morning :)
Krishna Institute of Medical Sciences Ltd

Krishna Institute of Medical Sciences Ltd

KIMS Share Price

NSE
₹740.551.38% (+10.05)
High
—
—
Low
—
—
Returns
—
—
Loading...
1D
1W
1M
3M
6M
1Y
3Y
5Y
Max
SIP

With a market cap of ₹31,103 cr, stock is ranked 279

Stock is 2.28x as volatile as Nifty

KIMS Stock Scorecard

Performance

Avg

Price return has been average, nothing exciting

Valuation

High

Seems to be overvalued vs the market average

Growth

Low

Lagging behind the market in financials growth

Profitability

High

Showing good signs of profitability & efficiency

Entry point

Good

The stock is underpriced and is not in the overbought zone

Red flags

Low

No red flag found

How to use scorecard? Learn more

With a market cap of ₹31,103 cr, stock is ranked 279

Stock is 2.28x as volatile as Nifty

KIMS Performance & Key Metrics

KIMS Performance & Key Metrics

No LabelNo LabelPB RatioPB RatioDividend YieldDiv. Yield
152.2412.16—
Sector PESector PESector PBSector PBSector Div YldSctr Div Yld
43.845.870.49%

KIMS Analyst Ratings & Forecast

Detailed Forecast Detailed Forecast 
100%
Analysts have suggested that investors can buy this stock

from 15 analysts

Price Upside

Earnings Growth

Rev. Growth

See Detailed Forecast

KIMS Company Profile

Krishna Institute of Medical Sciences Ltd is engaged in the business of rendering medical and healthcare services. Its hospital network is spread across Andhra Pradesh,Telangana, Karnataka, Odisha, Tamil Nadu and Central India.

Investor Presentation

View older View older 

Nov 4, 2026

PDF
View Older Presentations

KIMS Similar Stocks (Peers)

Compare with peers Compare with peers 

KIMS Similar Stocks (Peers)

Compare with peers Compare with peers 
PE Ratio
62.82
62.82
1Y Return
9.71%
9.71%
Buy Reco %
86.67
86.67
PE Ratio
60.81
60.81
1Y Return
18.92%
18.92%
Buy Reco %
84.00
84.00
PE Ratio
92.38
92.38
1Y Return
0.61%
0.61%
Buy Reco %
66.67
66.67
PE Ratio
152.74
152.74
1Y Return
3.83%
3.83%
Buy Reco %
91.67
91.67
PE Ratio
56.36
56.36
1Y Return
22.58%
22.58%
Buy Reco %
90.00
90.00
Compare with Peers

KIMS Sentiment Analysis

KIMS Sentiment Analysis

New
Crisp summary & key insights to decode earnings calls instantly

KIMS Stock Summary · August 2026

Management struck a strongly constructive tone, saying the quarter extended a powerful growth run as revenue crossed the INR 1,000 crore mark and reached INR 1,196 crore, up 36.1% year over year, while EBITDA rose 20.1% to INR 240 crore with margin broadly steady at 20.1%. They linked the performance to robust demand across the hospital network, with double-digit inpatient and outpatient volume growth and improving revenue per bed and per patient, while also acknowledging that profitability lagged topline expansion, as PAT fell to INR 37 crore from INR 85 crore a year earlier. Balance-sheet repair was another priority, with the oversubscribed INR 1,500 crore QIP used to cut debt to about INR 2,400 crore from INR 3,250 crore. Management also highlighted the rapid ramp-up of new units, especially Kondapur and Mahadevapura, and said Kerala remains in a growth phase with near-term EBITDA margins in single digits before improving to mid-teens next fiscal year. Looking ahead, they said expansion will stay focused on core geographies and on stabilizing recent openings before pursuing additional greenfield opportunities.

KIMS Stock Growth Drivers
KIMS Stock Growth Drivers
8
  • Strong Revenue and EBITDA Growth

    The company delivered a very strong start to FY27, with revenue crossing the INR 1,000

  • Healthy Operating Demand and Volume Expansion

    Underlying demand remained robust across the network, with both inpatient and outpatient activity growing strongly.

KIMS Stock Challenges
KIMS Stock Challenges
3
  • Lower profitability despite strong revenue growth

    The company delivered robust top-line and EBITDA growth, but bottom-line performance weakened materially. PAT fell

  • Temporary drag from the old Kondapur hospital

    The legacy Kondapur facility continues to weigh on results because it is still operating for

KIMS Forecast

KIMS Forecasts

Price

Revenue

Earnings

KIMS

KIMS

Income

Balance Sheet

Cash Flow

KIMS Income Statement

KIMS Income Statement

Loading...

Quartermar 2024jun 2024sep 2024dec 2024mar 2025jun 2025sep 2025dec 2025mar 2026jun 2026
Total Revenue637.60693.00782.30790.20812.20878.70964.901,002.901,086.901,196.90
Operating & Other expensessubtract474.90509.00559.20585.20598.90679.00757.00798.80879.00956.10
Depreciation/Amortizationsubtract46.3039.0041.0044.7052.6053.4066.1078.7085.00100.80
Interest & Other Itemssubtract16.4017.9019.9025.7026.7032.6045.0056.8068.1083.40
Taxes & Other Itemssubtract34.5040.5054.8045.9032.2035.1029.9015.2012.3015.10
EPS1.642.162.682.222.541.961.671.331.061.04

KIMS Company Updates

Annual Report and Investor Presentation updates mentioned here are as reported by the company to the exchange
FY 2027FY 2027

Annual Report Pending

Investor Presentation

Nov 4PDF
Aug 3PDF
FY 2026FY 2026

Annual report

PDF

Investor Presentation

May 16PDF
Feb 6PDF
Nov 11PDF
+2 more
FY 2025FY 2025

Annual report

PDF

Investor Presentation

May 12PDF
Feb 6PDF
Nov 9PDF
FY 2024FY 2024

Annual report

PDF
FY 2023FY 2023

Annual report

PDF
FY 2022FY 2022

Annual report

PDF
 

KIMS Stock Peers

KIMS Past Performance & Peer Comparison

KIMS Past Performance & Peer Comparison

Comparing 3 stocks from 
Health CareHospitals & Diagnostic Centres

Loading...

StockPE RatioPE RatioPB RatioPB RatioDiv. YieldDividend Yield
Krishna Institute of Medical Sciences Ltd125.4012.16—
Apollo Hospitals Enterprise Limited62.8212.390.23%
Max Healthcare Institute Limited60.818.400.22%
Manipal Health Enterprises Limited92.389.97—
ScreenerCompare valuation on Screener

KIMS Stock Price Comparison

Compare KIMS with any stock or ETF
Compare KIMS with any stock or ETF
KIMS
Loading...

KIMS Holdings

KIMS Shareholdings

KIMS Promoter Holdings Trend

KIMS Promoter Holdings Trend

Decreased Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has decreased by 1.45%

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

KIMS Institutional Holdings Trend

KIMS Institutional Holdings Trend

Total Retail Holding
Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.

In last 3 months, retail holding in the company has almost stayed constant

Foreign Institutional Holding
Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock

In last 3 months, foreign institutional holding of the company has almost stayed constant

Tickertape Separator

KIMS Shareholding Pattern

KIMS Shareholding Pattern

Retail and OthersForeign InstitutionsOther Domestic InstitutionsMutual FundsTotal Promoter Holding32.66%28.21%5.01%15.01%19.11%

Dec 2025

Mar 2026

Jun 2026

Sep 2026

KIMS Shareholding History

KIMS Shareholding History

JunSepDec '25MarJunSep15.54%15.03%14.33%14.57%14.74%15.01%

Mutual Funds Invested in KIMS

Mutual Funds Invested in KIMS

No mutual funds holding trends are available

Top 5 Mutual Funds holding Krishna Institute of Medical Sciences Ltd




Funds (Top 5)Market-cap heldWeight3M holding changePortfolio rank
(3M change)
2.7085%2.04%-0.21%7/88 (0)
2.6760%2.00%-0.50%42/80 (-33)
2.4646%2.46%-0.34%2/141 (0)

Compare 3-month MF holding change on Screener

KIMS Insider Trades & Bulk Stock Deals

KIMS Insider Trades & Bulk Stock Deals

Hmm, looks like there hasn't been any net deal activity in the last 6 months

smallcases containing KIMS stock

smallcases containing KIMS stock

Looks like this stock is not in any smallcase yet.

KIMS Events

KIMS Events

KIMS Dividend Trend

No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year

KIMS has not given any dividends in last 5 years

Dividends

Corp. Actions

Announcements

Legal Orders

KIMS Dividend Trend

No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year

KIMS has not given any dividends in last 5 years

KIMS Dividends

KIMS Dividends

Hmm, looks like data is unavailable here. Please come back after some time

KIMS Stock News & Opinions

KIMS Stock News & Opinions

Corporate
Corporate
KIMS Limited approved merger with KIMS Hospitals to streamline corporate structure

Krishna Institute of Medical Sciences Limited has approved a scheme of amalgamation with its wholly-owned subsidiary, KIMS Hospitals Private Limited, according to a regulatory filing on Thursday. The merger, which will simplify the group's corporate structure and eliminate multiple legal entities, was recommended by the company's audit committee and is expected to optimize asset utilization and reduce compliance costs. KIMS Hospitals Private Limited has a paid-up capital of Rs 65,99,99,990, while Krishna Institute of Medical Sciences Limited has a paid-up capital of Rs 84,00,12,968.

2 hours agoCapital Market - Live
Corporate
Corporate
Krishna Institute re-appoints Bollineni and Rao to leadership roles for five years

Krishna Institute of Medical Sciences Limited announced the re-appointment of Dr. Abhinay Bollineni as Director & CEO for a further term of 5 years, Dr. Bhaskara Rao Bollineni as Chairman & Managing Director for a further term of five years including continuation beyond the age of 70 years, and Ms. Dandamudi Anitha as Whole-time Director for a term of 5 years, effective January 18, 2027, and April 1, 2027, respectively.

2 hours agoCapital Market - Live
Corporate
Corporate
KIMS to acquire 51% stake in Sarvottam Health Care for up to Rs 80 crore

Krishna Institute of Medical Sciences Limited (KIMS) has entered into definitive agreements to acquire a 51% equity stake in Sarvottam Health Care Private Limited, Kakinada, for an aggregate consideration of up to Rs 80.00 crore. The acquisition, which does not constitute a related party transaction, is being made as a strategic investment and will be completed in due course, with KIMS remitting the consideration based on a valuation report from BDO Valuation Advisory LLP. Sarvottam Health Care Private Limited, operating as Trust Multi Speciality Hospital, has a turnover of Rs 84.83 crore for fiscal year 2025-26 and is located in Kakinada, Andhra Pradesh.

6 days agoCapital Market - Live
Corporate
Corporate
KIMS acquires 5.82% stake in Ushahkal Abhinav Specialty Hospital for Rs 15 crore

Krishna Institute of Medical Sciences Limited (KIMS) has acquired a 5.82% stake in Ushahkal Abhinav Specialty Hospital LLP (Sangli) for an aggregate consideration of Rs 15.00 crore, the company announced on Tuesday. The acquisition, described as a strategic investment, was based on a valuation report issued by BDO Valuation Advisory LLP and involved a primary infusion of capital. Ushahkal Abhinav Specialty Hospital LLP, founded in 2022, is a quaternary care facility with a current capacity of 316 beds and potential for expansion to over 500 beds, and reported a turnover of Rs 80.42 crore for fiscal year 2025-26.

6 days agoCapital Market - Live
Corporate
Corporate
Krishna Institute to review Q2 financial results at board meeting November 4, 2026

Krishna Institute of Medical Sciences Limited will hold a board meeting on Wednesday, November 04, 2026, to consider and approve the unaudited standalone and consolidated financial results for the second quarter and half-year ended September 30, 2026, according to a regulatory filing with the Bombay Stock Exchange and the National Stock Exchange. The company has closed the trading window for its equity shares for designated persons from October 01, 2026, until 48 hours after the financial results are made public.

1 week agoCapital Market - Live
Corporate
Corporate
Krishna Institute of Medical Sciences Limited files regulatory certificate with MUFG Intime India

Krishna Institute of Medical Sciences Limited submitted a certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended September 30, 2026, as received from MUFG Intime India Private Limited, formerly known as Link Intime India Private Limited, its Registrar and Share Transfer Agent.

3 weeks agoCapital Market - Live
Corporate
Corporate
Krishna Institute of Medical Sciences to acquire up to 22% stake in Splendid Hospitals

Krishna Institute of Medical Sciences Limited announced that its board approved the acquisition of an equity stake in Splendid Hospitals Private Limited (Kompally) for up to Rs 40.00 crore via primary infusion. The acquisition, which does not constitute a related party transaction, will see Krishna Institute of Medical Sciences acquire up to 22% of equity shares in Splendid Hospitals, a healthcare entity based in Kompally, Telangana, with the potential to expand to over 225 beds. The acquisition is expected to be completed on or before March 31, 2027, based on a valuation report from BDO Valuation Advisory LLP.

4 weeks agoCapital Market - Live
Corporate
Corporate
Krishna Institute to acquire 51% stake in Sarvottam Health Care for up to Rs 80 crore

Krishna Institute of Medical Sciences Limited announced that its board approved the acquisition of up to 51% equity stake in Sarvottam Health Care Private Limited (Kakinada) for an investment of up to Rs 80.00 crore, with the acquisition expected to be completed on or before October 31, 2026. Sarvottam Health Care Private Limited, operating as Trust Multi Speciality Hospital in Kakinada, Andhra Pradesh, commenced operations in 2010 and currently has a capacity of 183 beds, with a turnover of Rs 84.83 crore in fiscal year 2026.

4 weeks agoCapital Market - Live
Corporate
Corporate
KIMS to acquire up to 51% stake in Insignia Healthcare for Rs 30.35 per share

Krishna Institute of Medical Sciences Limited announced that its board approved the acquisition of up to 51% equity stake in Insignia Healthcare Private Limited (KIMS-SIKHARA), an operations and management entity, for a cash consideration of Rs 30.35 per equity share. The acquisition, which is expected to be completed within 12 to 24 months, will be executed as a strategic investment and does not fall under related party transactions. Insignia Healthcare Private Limited, incorporated in 2018 and based in Guntur, Andhra Pradesh, reported a turnover of Rs 104.5 crore in fiscal year 2025.

4 weeks agoCapital Market - Live
Corporate
Corporate
KIMS to acquire 6% stake in Ushahkal Abhinav Specialty Hospital for up to Rs 15 crore

Krishna Institute of Medical Sciences Limited announced that its board approved the acquisition of a 6% stake in Ushahkal Abhinav Specialty Hospital LLP (Sangli) for up to Rs 15 crore via primary infusion, on or before October 31, 2026. The acquisition, based on a valuation report by BDO Valuation Advisory LLP, will see KIMS manage and operate the 316-bed quaternary care facility, branded as “KIMS-UAIMS,” which was founded in 2022 and is located in Sangli, Maharashtra. Ushahkal Abhinav Specialty Hospital LLP reported a turnover of Rs 80.42 crore for fiscal year 2025-26.

4 weeks agoCapital Market - Live

Frequently asked questions

  1. The share price of KIMS as on 4th November 2026 is ₹740.55. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.

  2. The past returns of Krishna Institute of Medical Sciences Ltd (KIMS) share are
    • Past 1 week: 6.40%
    • Past 1 month: 1.45%
    • Past 3 months: -6.35%
    • Past 6 months: 9.10%
    • Past 1 year: 3.98%
    • Past 3 years: 100.34%
    • Past 5 years: 221.20%

  3. Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Krishna Institute of Medical Sciences Ltd (KIMS) is ₹31103.58 Cr as of 4th November 2026.

  4. The 52-week high of Krishna Institute of Medical Sciences Ltd (KIMS) is ₹858 and the 52-week low is ₹575.80.

  5. The P/E (price-to-earnings) ratio of Krishna Institute of Medical Sciences Ltd (KIMS) is 125.40. The P/B (price-to-book) ratio is 12.16.

  6. Krishna Institute of Medical Sciences Ltd (KIMS) belongs to the Health Care sector & Hospitals & Diagnostic Centres sub-sector.

  7. You can directly buy Krishna Institute of Medical Sciences Ltd (KIMS) shares on Tickertape. Simply sign up, connect your demat account and place your order.